Fresenius Kabi

Fresenius Kabi

Fresenius Kabi is a multinational company specialised in medicines and technologies for infusion, transfusion and clinical nutrition used for the care of critically ill patients or those suffering from chronic diseases.
The company develops, manufactures and sells pharmaceutical products and medical devices and employs approximately 32,500 people worldwide. Fresenius Kabi AG is wholly owned by Fresenius SE & Co. KGaA Healthcare Group.

Needs

Fresenius Kabi worked with CPL CONCORDIA to pursue the goal of improving its energy efficiency. The annual energy needs of the plant are equal to 13,057 MWh of electricity and 17,500 MWh of thermal energy in the form of steam and hot water.

Solutions

Besides having designed a tri-generation plant for the production facility in Isola della Scala, Verona, CPL CONCORDIA has planned plant renovations including:

• Tri-generation plant with an electric capacity of 1.4 MWe, thermal capacity of 1.544 MWt and cooling capacity of 1.035 MWf, to support production cycles
• Technological upgrades of the process water preheating system
• Replacement of the hot water storage tanks
• Replacement of the hot water absorption chiller
• Replacement of temperature management/monitoring systems for technological systems

With more than 35 years of experience and over 500 installed plants, CPL is the most reliable partner for the construction and maintenance of co-generation plants fuelled by methane and biogas, able to ensure the best management and maintenance performance to maximise energy efficiency and profit for the benefit of customers and their businesses.

Advantages

The revamping carried out at Fresenius Kabi will result in a significant improvement in terms of energy distribution efficiency, with high energy conversion rates.
The primary energy savings thanks to the revamping amounted to 6.5%, thus contributing to a total primary energy savings (with tri-generation) equal to 25.5%.